Log in

Start Your Membership Now

In October 2021, Johns Hopkins Medicine announced that the National Institute on Drug Abuse (NIDA) within the federal National Institutes of Health, had awarded a grant of $4 million to fund a study using psilocybin, a psychedelic compound, as a therapeutic agent for smoking cessation. It is the first such grant awarded by the United States government for research on psilocybin int eh context of tobacco use in 50 years.

The multi-site, three-year study will be led by researchers with Johns Hopkins Medicine in collaboration with researchers with the University of Alabama at Birmingham and with New York . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: